Predicting the disaster - The role of CRP in acetabular surgery.


Journal

Clinical biochemistry
ISSN: 1873-2933
Titre abrégé: Clin Biochem
Pays: United States
ID NLM: 0133660

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 01 02 2021
revised: 16 04 2021
accepted: 19 04 2021
pubmed: 26 4 2021
medline: 10 8 2021
entrez: 25 4 2021
Statut: ppublish

Résumé

Acetabular fractures represent a complex surgical challenge. Given the heterogenous fracture pattern, the patient characteristics and spectrum of complications demand individual solutions. Surgical site infections (SSI) threaten osteosynthesis, and early detection of them and treatment remain crucial. What is the value of postoperative C-reactive protein (CRP) in this group of patients as well as its normal course? 115 patients with isolated fractures of the acetabulum were retrospectively evaluated. CRP, white blood cell count (WBC) and fracture patterns as well as patient characteristics were assessed for 20 days following operative fixation of the acetabular fracture (n = 71) and in fractures that were managed conservatively (n = 44). Twelve patients suffered an infectious complication. With a one-phase decay, 70.55% of the variance of postoperative CRP kinetics was predicted. To anticipate maximum CRP as well as an infection, the preoperative CRP represented the best prognostic parameter. To predict an infection, the single variable "peak CRP value above 100 mg/l" resulted in a sensitivity and specificity of 91.67% and 36.21%, respectively. Combining a second peak of CRP with maximum CRP and day 5 CRP value for receiver-operating characteristic (ROC) analysis resulted in 83.3% and 88.1%, respectively. Predicting surgical site infections after an acetabular fracture is most predictive when analyzing the maximum overall CRP, the second peak and the CRP after day 5. With a combination of these parameters, a sensitivity and specificity of 83.3% and 88.1% to detect an infection was achieved.

Identifiants

pubmed: 33895126
pii: S0009-9120(21)00123-5
doi: 10.1016/j.clinbiochem.2021.04.020
pii:
doi:

Substances chimiques

C-Reactive Protein 9007-41-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

48-55

Informations de copyright

Copyright © 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Auteurs

D Saul (D)

Department of Trauma, Orthopedics and Reconstructive Surgery, Georg-August-University of Goettingen, Germany; Kogod Center on Aging and Division of Endocrinology, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: Dominik.Saul@med.uni-goettingen.de.

P Hünicke (P)

Department of Trauma, Orthopedics and Reconstructive Surgery, Georg-August-University of Goettingen, Germany.

K O Böker (KO)

Department of Trauma, Orthopedics and Reconstructive Surgery, Georg-August-University of Goettingen, Germany.

C Spering (C)

Department of Trauma, Orthopedics and Reconstructive Surgery, Georg-August-University of Goettingen, Germany.

A K Maheshwari (AK)

Kogod Center on Aging and Division of Endocrinology, Mayo Clinic, Rochester, MN 55905, USA.

M Acharya (M)

Trauma & Orthopaedics, Southmead Hospital, Bristol BS10 5NB, United Kingdom.

W Lehmann (W)

Department of Trauma, Orthopedics and Reconstructive Surgery, Georg-August-University of Goettingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH